Description
Fischer Medical Ventures Ltd receives new ISIN INE771F01041 for equity shares sub-divided from Rs.10 to Re.1, effective September 12, 2025.
Summary
BSE has assigned a new ISIN number INE771F01041 to Fischer Medical Ventures Ltd (Scrip Code: 524743) following the sub-division of equity shares from face value of Rs.10 to Re.1. The new ISIN will be effective for trades from September 12, 2025.
Key Points
- Company: Fischer Medical Ventures Ltd (Scrip Code: 524743)
- New ISIN: INE771F01041
- Share sub-division: From Rs.10 per share to Re.1 per share
- Effective date: September 12, 2025 (Ex-Date)
- DR Number: 714/2025-2026
Regulatory Changes
New ISIN number issued to reflect the change in face value of equity shares following corporate action of share sub-division.
Compliance Requirements
- Trading members must update their systems with the new ISIN number
- All trades from September 12, 2025 onwards must use the new ISIN INE771F01041
- Systems must be configured to handle the new share denomination of Re.1 each
Important Dates
- September 12, 2025: Ex-date for new ISIN effectiveness
- September 10, 2025: Notice publication date
Impact Assessment
Medium impact on trading operations requiring system updates to accommodate the new ISIN and share denomination. Investors and trading members need to ensure proper mapping of old and new ISIN for seamless trading operations.
Impact Justification
ISIN changes affect trading systems and investor records but are routine corporate actions with clear timelines